In:
Macedonian Pharmaceutical Bulletin, Macedonian Pharmaceutical Association, Vol. 57 ( 2011), p. 3-16
Abstract:
Ionotropic glutamate receptors (iGluRs) constitute a family of ligand gated ion channels subdivided in three classes, NMDA, AMPA (iGluA1-4) and KA (1-5) according to the agonists that selectively activate them. iGluRs are tetrameric assemblies of highly homologous
receptor subunits. They are critically important for normal brain function and are considered to be involved on neurological disorders and degenerative diseases such as schizophrenia, Alzheimer’s disease, brain damage following stroke and epilepsy. Since the first publication of the structure of recombinant soluble protein of ligand binding domain of GluA2 extensive studies on this group of receptors were performed and many crystal structures as complexes of GluA2-LBD with agonists, partial agonists and antagonists were obtained. The structural information in combination with functional data makes good platform for consecutive investigation and design of new selective drugs which will be used in treatment of neurodegerative diseases.
Type of Medium:
Online Resource
ISSN:
1857-8969
,
1409-8695
DOI:
10.33320/maced.pharm.bull.2011.57
DOI:
10.33320/MacedPharmBull
DOI:
10.33320/maced.pharm.bull.2011.57.001
Language:
English
Publisher:
Macedonian Pharmaceutical Association
Publication Date:
2011
Permalink